ClinicalTrials.Veeva

Menu

Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors (TEXTIS)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

Text Messaging
Germ Cell Tumor
Follow-up
Compliance, Patient

Treatments

Other: short message service

Study type

Observational

Funder types

Other

Identifiers

NCT03868176
P/2018/404

Details and patient eligibility

About

This study will evaluate the impact of Short Message Service (SMS) on compliance with surveillance of patients with germ-cell tumors. Patients will be randomized in a 2:1 ratio to get 2 groups : (1) patients will receive reminder SMS before appointment detailing the date of consultation and exams to be performed before; (2) standard of care without SMS.

Enrollment

235 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with germ cell tumor.
  • Patient with a mobile phone.
  • Patient on surveillance.

Exclusion criteria

  • Testicular cancer without germ cell component.
  • Prior history of other malignancy except for: cutaneous cancers excluding melanoma, superficial bladder tumor, localized prostate cancer with undetectable PSA.
  • Cognitive condition that would preclude patient's understanding and completion of study procedures.

Trial design

235 participants in 2 patient groups

Experimental: reminder SMS before appointment
Description:
SMS before appointment detailing the date of consultation and exams to be performed before
Treatment:
Other: short message service
Active comparator: standard of care

Trial contacts and locations

1

Loading...

Central trial contact

Elise ROBERT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems